BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/30/2024 3:48:47 AM | Browse: 109 | Download: 402
 |
Received |
|
2024-07-30 02:06 |
 |
Peer-Review Started |
|
2024-08-09 06:07 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-09-07 23:05 |
 |
Revised |
|
2024-09-19 14:13 |
 |
Second Decision |
|
2024-10-16 02:42 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-10-16 08:04 |
 |
Articles in Press |
|
2024-10-16 08:04 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-10-29 16:33 |
 |
Publish the Manuscript Online |
|
2024-11-30 03:48 |
ISSN |
1948-9358 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Endocrinology & Metabolism |
Manuscript Type |
Letter to the Editor |
Article Title |
Intestinal glucagon-like peptide-1: A new regulator of impaired counterregulatory responses to hypoglycemia in type 1 diabetes mellitus
|
Manuscript Source |
Invited Manuscript |
All Author List |
Le-Rong Liu, Yuan-Yuan Luo, Pei-Zhu Su, Cong Zhang and Zhao-Tao Li |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China |
82400966 |
Guangdong Basic and Applied Basic Research Foundation |
2021A1515111025 |
Science and Technology Projects in Guangzhou |
2024A04J5170 |
|
Corresponding Author |
Cong Zhang, MD, PhD, Department of Gastroenterology, The First People's Hospital of Foshan, No. 81 Lingnan Avenue North, Foshan 528000, Guangdong Province, China. zhangc57@mail2.sysu.edu.cn |
Key Words |
Glucagon-like peptide-1; Impaired counterregulation; Type 1 diabetes mellitus; Sympathetic-adrenal reflex; Glucagon |
Core Tip |
Jin et al reported that excessive intestinal glucagon-like peptide-1 (GLP-1) exacerbates impaired counterregulatory responses in individuals with type 1 diabetes mellitus (T1DM). By elucidating the molecular mechanisms through which GLP-1 disrupts the sympathetic-adrenal reflex and inhibits glucagon secretion, the authors explored the significant role of GLP-1 in counterregulatory failure. Further research is needed to understand the potential impact of GLP-1 and its analogs on counterregulatory responses in T1DM patients and to evaluate their prospects as adjunctive treatments for preventing and treating hypoglycemia in patients with diabetes. |
Publish Date |
2024-11-30 03:48 |
Citation |
<p>Liu LR, Luo YY, Su PZ, Zhang C, Li ZT. Intestinal glucagon-like peptide-1: A new regulator of impaired counterregulatory responses to hypoglycemia in type 1 diabetes mellitus. <i>World J Diabetes</i> 2025; 16(1): 99726</p> |
URL |
https://www.wjgnet.com/1948-9358/full/v16/i1/99726.htm |
DOI |
https://dx.doi.org/10.4239/wjd.v16.i1.99726 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345